Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations - Aurinia Pharmaceuticals (NASDAQ:AUPH)
2 Articles
2 Articles
Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations - Aurinia Pharmaceuticals (NASDAQ:AUPH)
Aurinia Pharmaceuticals reported Q4 earnings of 1 cent per share, beating estimates, with LUPKYNIS sales up 36%.
What is autoimmune disease? - Breakthrough T1D
March is Autoimmune Disease Awareness Month. Breakthrough T1D is taking this opportunity to provide education and shed light on these often “invisible” conditions. What is autoimmune disease? Autoimmune diseases occur when a person’s immune system wrongly attacks the body’s healthy cells, tissues, and organs. This response can result in a range of conditions, depending on which parts of the body are affected. In type 1 diabetes (T1D), the immune…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage